DG
74
-2
ADSK
58
-4
EMN
62
-3
COF
65
-3
CPB
39
2
CCL
65
-3
AES
55
-3
AMT
37
-2
CMG
54
4
AMG
75
-7
DAL
70
-3
COST
48
-2
BBY
45
-4
CFG
93
-2
ABT
41
3
AA
67
-5
ED
39
3
EMC
60
-12
ETR
52
-2
AEP
59
-2
DG
74
-2
ADSK
58
-4
EMN
62
-3
COF
65
-3
CPB
39
2
CCL
65
-3
AES
55
-3
AMT
37
-2
CMG
54
4
AMG
75
-7
DAL
70
-3
COST
48
-2
BBY
45
-4
CFG
93
-2
ABT
41
3
AA
67
-5
ED
39
3
EMC
60
-12
ETR
52
-2
AEP
59
-2
Financhill
Back

HIVE Digital Technologies Ltd. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
30

HIVE
HIVE Digital Technologies Ltd.

Last Price:
$3.0600
Seasonality Move:
335.65%
Sell
34

NKTR
Nektar Therapeutics

Last Price:
$54.70
Seasonality Move:
11.58%
Sell
30
HIVE Digital Technologies Ltd. (HIVE) is a Sell

Is HIVE Digital Technologies Ltd. a Buy, Sell or Hold?

  • The current HIVE Digital Technologies Ltd. [HIVE] share price is $3.0600. The Score for HIVE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • HIVE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HIVE Stock Price Chart

What is HIVE Digital Technologies Ltd.'s stock price today?

  • The HIVE Digital Technologies Ltd. share price today is $3.0600
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HIVE is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

HIVE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.33 Sell
Relative Strength Index (14 RSI): 37.09 Sell
Chaikin Money Flow: -8009828 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

HIVE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.19 Sell
20-day SMA: 3.2 Sell
50-day SMA: 4.58 Sell
200-day SMA: 2.79 Buy
8-day EMA: 3.18 Sell
20-day EMA: 3.42 Sell
50-day EMA: 3.84 Sell
200-day EMA: 3.33 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

HIVE Digital Technologies Ltd. Earnings Growth & HIVE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.14 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

HIVE Digital Technologies Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):